Uscom Ltd

ASX:UCM

Uscom Ltd. engages in the development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2003-12-10. The firm manages a network of distribution partners across the world for the sale of its equipment to hospitals and other medical care locations. Its geographic segments include Singapore, Australia, China, South East Asia, Europe and the United States. The firm has approximately three practice suites of devices in the field of cardiac, vascular and pulmonary monitoring, including the USCOM 1A, which is an hemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment, USCOM BP+, which is a supra systolic oscillometric Central Blood Pressure monitor that measures blood pressure and blood pressure waveforms only previously available using cardiac catheterization, and the Uscom SpiroSonic spirometers, which is a digital pulmonary testing device.